Group One Trading’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.96M | Buy |
3,300
+1,100
| +50% | +$548K | ﹤0.01% | 2091 |
|
|
2025
Q4 | $1.07M | Sell |
2,200
-25,100
| -92% | -$11.7M | ﹤0.01% | 2816 |
|
|
2025
Q3 | $11.4M | Buy |
27,300
+23,800
| +680% | +$8M | 0.02% | 820 |
|
|
2025
Q2 | $1.01M | Sell |
3,500
-4,900
| -58% | -$1.46M | ﹤0.01% | 2762 |
|
|
2025
Q1 | $2.59M | Buy |
+8,400
| New | +$2.88M | 0.01% | 1593 |
|
|
2024
Q4 | – | Sell |
-4,200
| Closed | -$1.51M | – | 8014 |
|
|
2024
Q3 | $1.51M | Sell |
4,200
-1,500
| -26% | -$507K | ﹤0.01% | 1961 |
|
|
2024
Q2 | $1.82M | Buy |
5,700
+4,000
| +235% | +$1.06M | 0.01% | 1531 |
|
|
2024
Q1 | $391K | Buy |
+1,700
| New | +$384K | ﹤0.01% | 2974 |
|
|
2023
Q4 | – | Sell |
-3,000
| Closed | -$678K | – | 8241 |
|
|
2023
Q3 | $678K | Buy |
+3,000
| New | +$691K | ﹤0.01% | 2627 |
|
|
2023
Q2 | – | Sell |
-22,400
| Closed | -$5.02M | – | 8251 |
|
|
2023
Q1 | $5.02M | Buy |
22,400
+22,300
| +22,300% | +$5.5M | 0.02% | 837 |
|
|
2022
Q4 | $27.8K | Buy |
+100
| New | +$25.2K | ﹤0.01% | 5397 |
|
|
2022
Q3 | – | Sell |
-100
| Closed | -$24K | – | 8304 |
|
|
2022
Q2 | $24K | Hold |
100
| – | – | ﹤0.01% | 6154 |
|
|
2022
Q1 | $18K | Buy |
+100
| New | +$19.1K | ﹤0.01% | 6832 |
|
|
2021
Q4 | – | Sell |
-1,300
| Closed | -$240K | – | 8880 |
|
|
2021
Q3 | $240K | Buy |
1,300
+900
| +225% | +$177K | ﹤0.01% | 4981 |
|
|
2021
Q2 | $72K | Buy |
400
+300
| +300% | +$57.1K | ﹤0.01% | 6265 |
|
|
2021
Q1 | $17K | Buy |
+100
| New | +$16.7K | ﹤0.01% | 6834 |
|
|
2020
Q2 | – | Sell |
-6,000
| Closed | -$569K | – | 6206 |
|
|
2020
Q1 | $569K | Sell |
6,000
-200
| -3% | -$19K | ﹤0.01% | 1966 |
|
|
2019
Q4 | $546K | Buy |
6,200
+5,200
| +520% | +$458K | ﹤0.01% | 2358 |
|
|
2019
Q3 | $80K | Buy |
1,000
+200
| +25% | +$16.1K | ﹤0.01% | 3706 |
|
|
2019
Q2 | $62K | Buy |
800
+700
| +700% | +$65.5K | ﹤0.01% | 3664 |
|
|
2019
Q1 | $12K | Buy |
+100
| New | +$11.7K | ﹤0.01% | 4218 |
|
|
2018
Q4 | – | Sell |
-1,600
| Closed | -$205K | – | 5444 |
|
|
2018
Q3 | $205K | Buy |
+1,600
| New | +$198K | ﹤0.01% | 2995 |
|
|
2017
Q4 | – | Sell |
-1,600
| Closed | -$188K | – | 5257 |
|
|
2017
Q3 | $188K | Buy |
+1,600
| New | +$204K | ﹤0.01% | 2804 |
|
|
2016
Q1 | – | Sell |
-2,400
| Closed | -$376K | – | 4974 |
|
|
2015
Q4 | $376K | Hold |
2,400
| – | – | ﹤0.01% | 2038 |
|
|
2015
Q3 | $315K | Hold |
2,400
| – | – | ﹤0.01% | 2165 |
|
|
2015
Q2 | $417K | Buy |
2,400
+500
| +26% | +$89.9K | 0.01% | 1935 |
|
|
2015
Q1 | $328K | Hold |
1,900
| – | – | 0.01% | 1956 |
|
|
2014
Q4 | $246K | Buy |
+1,900
| New | +$245K | ﹤0.01% | 2132 |
|
Other funds holding UTHR
ACA
VPM
VCM
Group One Trading's UTHR Position: Q1 2026 in Review
Group One Trading sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 1,169 shares — an estimated $582K sold.
Group One Trading first reported a position in UTHR in Q4 2014 and held it in 13 quarters. The position peaked at $2.11M in Q1 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Group One Trading reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 1,169 United Therapeutics shares in Q1 2026, an estimated $582K.
- Group One Trading first reported a position in United Therapeutics in Q4 2014 and held it in 13 quarters.
- Group One Trading's United Therapeutics position peaked at $2.11M in Q1 2025.
- 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.